PropertyValue
?:abstract
  • OBJECTIVE: With the ongoing COVID-19 pandemic, large numbers of people will receive one of the several medications proposed to treat COVID-19, including patients of reproductive age. Given that some medications have shown adverse effects on sperm quality, there might be a transgenerational concern. We aim at examining the association between drugs proposed to treat COVID-19 when taken by the father around conception and any pre-term birth or major birth defects in offspring in a nation-wide cohort study using Danish registry data. Offspring whose father filled at least one prescription of the following medications in the 3 months preceding conception were considered exposed: chloroquine, hydroxychloroquine, losartan, azithromycin, naproxen, dexamethasone and prednisone. RESULTS: For azithromycin and naproxen, large numbers of offspring were exposed (> 1800 offspring), and we found no association with adverse birth outcomes. For chloroquine, losartan and dexamethasone, exposure was intermediate (~ 900 offspring), and there was no statistically significant association with birth defects. For hydroxychloroquine and prednisone, exposure was limited (< 300 offspring). Our evidence suggests that azithromycin and naproxen are safe with respect to pre-term birth and birth defects. For the other drugs investigated larger exposures are needed for conclusive statements.
is ?:annotates of
?:creator
?:doi
?:doi
  • 10.1186/s13104-020-05358-x
?:journal
  • BMC_Res_Notes
?:license
  • cc-by
?:pdf_json_files
  • document_parses/pdf_json/34fcf77ee52720d2753fdeeab7b553da6c61502c.json
?:pmc_json_files
  • document_parses/pmc_json/PMC7647878.xml.json
?:pmcid
?:pmid
?:pmid
  • 33160408.0
?:publication_isRelatedTo_Disease
is ?:relation_isRelatedTo_publication of
?:sha_id
?:source
  • Medline; PMC
?:title
  • Risk of pre-term births and major birth defects resulting from paternal intake of COVID-19 medications prior to conception
?:type
?:year
  • 2020-11-07

Metadata

Anon_0  
expand all